Recent Tweets
[email protected] shares additional proof points for #biosimilars. Policymakers can keep the momentum going for patients and payers by supporting shared savings and other initiatives that increase access to biosimilars.
Big #biosimilar news: Ronny Gal @AB_insights calculates that #biosimilar savings are now $6.5 billion (annualized) and growing 👇
Spending down -31% for reference molecules
@ScottGottliebMD was right. We shouldn’t give up on biosimilars #notowel
(Sorry, no link to full report)
